Page last updated: 2024-09-04

moxifloxacin and Staphylococcal Infections

moxifloxacin has been researched along with Staphylococcal Infections in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.02)	18.2507
2000's	46 (46.46)	29.6817
2010's	40 (40.40)	24.3611
2020's	11 (11.11)	2.80

Authors

Authors	Studies
Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD	1
Frank, KL; Patel, R; Piper, KE; Reichert, EJ	1
Giamarellou, H; Kyroudi, A; Papalois, A; Pefanis, A; Skiadas, I; Triantafyllidi, H; Tsaganos, T	1
Arvieux, C; Bugnon, D; Caillon, J; Grossi, O; Hamel, A; Jacqueline, C; Potel, G	1
Appelbaum, PC; Bhagwat, SS; Kosowska-Shick, K; McGhee, P; Patel, MV	1
Bulitta, JB; Drusano, GL; Gusinde, J; Hennig, FF; Holzgrabe, U; Kinzig, M; Landersdorfer, CB; Sörgel, F	1
Brindha Devi, P; Janupally, R; Jeankumar, VU; Kulkarni, P; Medepi, B; Sriram, D; Suryadevara, P; Yogeeswari, P	1
Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ	1
Beuerman, RW; Chalasani, MLS; Iyer, A; Lakshminarayanan, R; Leng Goh, ET; Lloyd, DG; Madder, A; Mayandi, V; Parmar, A; Prior, SH; Singh, I; Taylor, EJ; Verma, NK	1
Bandow, JE; Hernández, MV; Kalscheuer, R; Meier, D; Muharini, R; Proksch, P; van Geelen, L	1
Bhagwat, S; Bhawsar, S; Deshpande, P; Joshi, S; Patel, M; Yeole, R	1
Cevallos, AV; Keenan, JD; Lee, MD; Lin, YB; Oji, NM; Seitzman, GD	1
Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N	1
Bocanegra-Ibarias, P; Camacho-Ortiz, A; Flores-Treviño, S; Perez-Alba, E; Vilchez-Cavazos, F; Villarreal-Salazar, V	1
Malani, M; Nirmal, J; Saha, S; Thodikayil, AT	1
Argudín, MA; Deplano, A; Dodemont, M; Nguyen, HA; Nguyen, TK; Nhung, PH; Tulkens, PM; Van Bambeke, F	1
Chhibber, T; Gondil, VS; Sinha, VR	1
Atta, S; Bhat, AK; Dhaliwal, D; Durrani, AF; Jhanji, V; Kowalski, RP; Mammen, A	1
Liu, Y; Wang, P; Xu, Y; Xu, Z	1
Graue-Hernandez, EO; Lichtinger, A; Navas, A; Polania-Baron, EJ; Santana-Cruz, O	1
Choreftaki, T; Galanopoulos, I; Giamarellos-Bourboulis, EJ; Giannitsioti, E; Kanellakopoulou, K; Papalois, A; Poultsides, LA; Soranoglou, V	1
Bori, G; Jutte, PC; Kampinga, GA; Morata, L; Nannan Panday, PV; Soriano, A; Tornero, E; Wouthuyzen-Bakker, M	1
Alves, P; Bozukova, D; Coimbra, P; Correia, IJ; Correia, TR; Gil, MH; Guiomar, AJ; Mata, JLGC; Pimenta, AFR; Serro, AP; Silva, D; Vieira, AP	1
Ahmed Khan, T; Azher, I; Sheikh, AK; Sheikh, M	1
Dhaliwal, DK; Kowalski, RP; Mammen, A; Romanowski, EG; Shanks, RMQ	1
Galvis, V; Gómez, MA; Grice, JM; Niño, CA; Tello, A	1
Chojnacki, M; Dunman, PM; Philbrick, A; Reed, JN; Tomaras, A; Wozniak, RAF; Wucher, B	1
Chalam, KV; Ng, C	1
Blanco, C; Núñez, MX	1
Blessmann, M; Cachovan, G; Heiland, M; Platzer, U; Rother, U; Schön, G; Sobottka, I; Stürenburg, E	1
Goriunov, SV; Prividentsev, AI; Stupin, VA; Vasin, VI; Zhilina, SV	1
Hussain, T; Liaqat, F; Muhammad, J; Nazir, J; Rabbani, M; Shaheen, AY; Sheikh, AA	1
Buyck, JM; Peyrusson, F; Tulkens, PM; Van Bambeke, F	1
Chang, SH; Chien, HI; Chien, ST; Hsu, CH; Hsueh, JC; Lee, PL; Lee, TM; Yang, MC; Yang, TF	1
Bharti, SK; Kesavan, K	1
Attisano, C; Cibinel, M; Furfaro, G; Giardini, F; Grandi, G; Grignolo, FM; Machetta, F; Panepinto, G; Pollino, C; Strani, G	1
Bisignano, G; Blanco, AR; Ginestra, G; Marino, A; Nostro, A	1
Werth, BJ	1
Arhin, FF; Belley, A; McKay, GA; Moeck, G; Neesham-Grenon, E; Parr, TR	1
Arias, CA; Cárdenas, AM; Castañeda, E; Díaz, L; Díaz, PL; Hidalgo, M; Reyes, J; Rincón, S; Vanegas, N	1
Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Pefanis, A; Sakka, V; Skiadas, I; Triantafyllidi, H	1
Horstkotte, MA; Knobloch, JK; Mack, D; Rohde, H; Von Osten, H	1
Galanopoulos, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Maris, I; Papalois, A; Soranoglou, V; Tsaganos, T; Tziortzioti, V	1
Ariza, J; Cabellos, C; Cabo, J; Euba, G; Gudiol, F; Murillo, O; Pachón, ME; Tubau, F; Verdaguer, R	1
Berkner, L; Hazarbassanov, R; Michaeli, A; Regenbogen, M; Varssano, D; Waisbourd, M	1
Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Shafiee, A	2
Carter, NJ; Scott, LJ	1
Cakici, H; Guven, M; Kocoglu, E; Ozturan, KE; Yucel, I	1
Aguado, JM; Caba, P; Chaves, F; Garcia-Reyne, A; Lizasoain, M; Llanos, F; López-Medrano, F; Resines, C; San Juan, R	1
Proksch, JW; Ward, KW	1
Balzli, CL; Caballero, AR; O'Callaghan, RJ; Tang, A; Weeks, AC	1
Lemaire, S; Tulkens, PM; Van Bambeke, F	1
Kim, JY; Kim, SY	1
Appelbaum, PC; Glupczynski, Y; Kosowska-Shick, K; Lemaire, S; Tulkens, PM; Van Bambeke, F	1
Khan, MR; Shah, SQ	1
Kim, SJ; Toma, HS	1
Acharya, NR; Cevallos, V; Fintelmann, RE; Gaynor, BD; Hoskins, EN; Keenan, JD; Lietman, TM	1
Bartell, J; Cupp, G; Garber, R; Stroman, D; Tauber, S; Vohra, F	1
Hartmann, B; Keller, F; Maus, S; Rothermund, L	1
Carelli, R; Forte, R; Magli, A; Rombetto, L	1
Chen, X; Guo, X; Shi, G; Wang, H; Wang, S; Zhang, X	1
Banerjee, P; Biswas, S; Chattopadhyay, C; Das, D; Mondal, KK; Ray, B	1
Bosjolie, A; Qiao, M; Shih, CY; Udell, IJ	1
Akova, YA; Asena, L; Bozkurt, A; Demiralay, E; Goktaş, MT; Karabay, G; Yaşar, U	1
Abb, J	1
Arvis, P; Bronner, S; Jehl, F; Monteil, H; Peter, JD; Ploy, MC; Prevost, G; Renault, C	1
Seral, C; Tulkens, PM; Van Bambeke, F	1
Cassone, M; Monaco, M; Pompeo, ME; Tarasi, A; Tarasi, D; Venditti, M	1
Ahmad, RN; Butt, T; Usman, M	1
Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA; Traidej, M	1
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA	3
Cetinkaya, Z; Ermis, SS; Kiyici, H; Ozturk, F	1
Aliprandis, E; Ciralsky, J; Herling, I; Katz, HR; Lai, H	1
Becker, K; Friedrich, AW; Peters, G; von Eiff, C	1
Garweg, JG; Kodjikian, L	1
Beckmann, J; Kalteis, T; Lehn, N; Lerch, K; Linde, HJ; Schaumburger, J; Schröder, HJ	1
Feiz, V; Kang, PC; Mirzaian, G; Moshirfar, M	1
Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S	1
Beckmann, J; Grifka, J; Handel, M; Kalteis, T; Lehn, N; Lerch, K; Schröder, HJ	1
Cars, O; Odenholt, I	1
Dubois, V; Grellet, J; Nguyen, HA; Quentin, C; Saux, MC	1
Flynn, HW; Harper, T; Miller, D	1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiyici, H; Ozturk, F	1
Jhanji, V; Satpathy, G; Sharma, N; Titiyal, J	1
Delgado, J; Diaz, LA; Galvis, V; Gómez, AJ; Tello, A; Valencia, F	1
Inoue, T; Kida, T; Naka, H; Sakaki, H; Tokushige, H; Wada, T	1
Balzli, CL; Caballero, AR; Huang, B; McCormick, CC; O'Callaghan, RJ; Smith, E; Tang, A; Wigington, L	1
Neiberg, MN; Sowka, J	1
Citron, DM; Goldstein, EJC; Rybak, MJ; Tyrrell, KL; Warren, YA	1
Engler, B; Fluit, AC; Hadding, U; Heinz, HP; Hofmann, B; Jones, ME; Lückefahr, M; Schmitz, FJ; Verhoef, J	1
Peters, G; von Eiff, C	1
Botzenhart, K; Dalhoff, A; Döring, G; Kaygin, H; Steinhuber, A; Worlitzsch, D	1
Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G	1
Berrington, AW; Gould, FK; Perry, JD	1
Bain, HH; Berrington, AW; Gould, FK; Koerner, RJ; Perry, JD	1
Entenza, JM; Glauser, MP; Moreillon, P; Que, YA; Vouillamoz, J	1

Reviews

2 review(s) available for moxifloxacin and Staphylococcal Infections

Article	Year
Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review. Medicine, 2020, Jun-26, Volume: 99, Issue:26 Topics: Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Empyema; Humans; Male; Middle Aged; Moxifloxacin; Pleural Effusion; Staphylococcal Infections; Staphylococcus; Tomography, X-Ray Computed	2020
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma. Archivos de la Sociedad Espanola de Oftalmologia, 2019, Volume: 94, Issue:2 Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Combined Modality Therapy; Contact Lenses, Hydrophilic; Corneal Ulcer; Facial Nerve Injuries; Facial Paralysis; Female; Humans; Insulin; Keratitis; Middle Aged; Moxifloxacin; Neuroma, Acoustic; Postoperative Complications; Staphylococcal Infections; Trigeminal Nerve Injuries; Vancomycin	2019

Article

Year

Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review.

Medicine, 2020, Jun-26, Volume: 99, Issue:26

Topics: Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Empyema; Humans; Male; Middle Aged; Moxifloxacin; Pleural Effusion; Staphylococcal Infections; Staphylococcus; Tomography, X-Ray Computed

2020

Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma.

Archivos de la Sociedad Espanola de Oftalmologia, 2019, Volume: 94, Issue:2

Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Combined Modality Therapy; Contact Lenses, Hydrophilic; Corneal Ulcer; Facial Nerve Injuries; Facial Paralysis; Female; Humans; Insulin; Keratitis; Middle Aged; Moxifloxacin; Neuroma, Acoustic; Postoperative Complications; Staphylococcal Infections; Trigeminal Nerve Injuries; Vancomycin

2019

Trials

4 trial(s) available for moxifloxacin and Staphylococcal Infections

Article	Year
Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections. Acta odontologica Scandinavica, 2014, Volume: 72, Issue:7 Topics: Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteroidaceae Infections; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Fusobacterium Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periapical Abscess; Periodontal Abscess; Prospective Studies; Radiography; Staphylococcal Infections; Streptococcal Infections; Tooth Diseases; Virulence; Young Adult	2014
[Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome]. Khirurgiia, 2014, Issue:10 Topics: Anti-Bacterial Agents; Combined Modality Therapy; Diabetic Foot; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Surgical Procedures, Operative; Treatment Outcome	2014
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology, 2011, Volume: 118, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Levofloxacin; Middle Aged; Moxifloxacin; Nasopharynx; Ofloxacin; Prospective Studies; Quinolines; Staphylococcal Infections	2011
Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. Advances in therapy, 2011, Volume: 28, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Young Adult	2011

Other Studies

93 other study(ies) available for moxifloxacin and Staphylococcal Infections

Article	Year
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance	2005
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; DNA, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillin-Binding Proteins; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus; Tetracycline	2007
Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Aortic Valve; Aza Compounds; Dexamethasone; Disease Models, Animal; Echocardiography; Endocarditis, Bacterial; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2007
In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Animals; Anti-Bacterial Agents; Arthritis, Experimental; Arthritis, Infectious; Aza Compounds; Cloxacillin; Colony Count, Microbial; Fluoroquinolones; Half-Life; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Vancomycin	2007
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance	2009
Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Arthroplasty, Replacement, Hip; Aza Compounds; Chromatography, High Pressure Liquid; Female; Femur; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2009
Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus. Chemical biology & drug design, 2015, Volume: 86, Issue:4 Topics: Animals; DNA Gyrase; Furans; Humans; Models, Molecular; Pyrroles; Staphylococcal Infections; Staphylococcus aureus; Thiophenes; Topoisomerase II Inhibitors; Zebrafish	2015
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety. Bioorganic & medicinal chemistry letters, 2015, Aug-01, Volume: 25, Issue:15 Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles	2015
Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo. Journal of medicinal chemistry, 2018, 03-08, Volume: 61, Issue:5 Topics: Animals; Depsipeptides; Drug Design; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Vancomycin-Resistant Enterococci	2018
The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria. Bioorganic & medicinal chemistry, 2019, 12-01, Volume: 27, Issue:23 Topics: Anti-Bacterial Agents; Cell Line; Chalcone; Fabaceae; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections	2019
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections. Bioorganic & medicinal chemistry letters, 2022, 05-01, Volume: 63 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperidines; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Structure-Activity Relationship	2022
Assessment of Antimicrobial Activity of Dehydrated Amniotic Membrane in Infectious Keratitis: A Small Retrospective Case Series and In Vitro Study. Cornea, 2021, Oct-01, Volume: 40, Issue:10 Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Adolescent; Adult; Amnion; Anti-Bacterial Agents; Eye Infections, Bacterial; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae	2021
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen International journal of molecular sciences, 2023, Jan-19, Volume: 24, Issue:3 Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus	2023
Planktonic and biofilm states of Staphylococcus aureus isolated from bone and joint infections and the in vitro effect of orally available antibiotics. Journal of applied microbiology, 2023, Dec-01, Volume: 134, Issue:12 Topics: Anti-Bacterial Agents; Biofilms; Doxycycline; Humans; Microbial Sensitivity Tests; Moxifloxacin; Plankton; Rifampin; Staphylococcal Infections; Staphylococcus aureus	2023
Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis. Carbohydrate polymers, 2024, Jan-15, Volume: 324 Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Cellulose; Cornea; Eye Infections, Bacterial; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus	2024
Antibiotic Resistance, Biofilm Formation, and Intracellular Survival As Possible Determinants of Persistent or Recurrent Infections by Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:6 Topics: Anti-Bacterial Agents; Biofilms; DNA-Binding Proteins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Phagocytes; Reinfection; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers; Vietnam	2020
Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice. AAPS PharmSciTech, 2020, Jan-02, Volume: 21, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biofilms; Boswellia; Burns; Chitosan; Drug Compounding; Gels; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus; Wound Infection	2020
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes. American journal of ophthalmology, 2020, Volume: 214 Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Combinations; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vancomycin	2020
Treatment of Severe Infectious Keratitis With Scleral Contact Lenses as a Reservoir of Moxifloxacin 0.5. Cornea, 2021, Jul-01, Volume: 40, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspergillosis; Contact Lenses; Corneal Ulcer; Drug Carriers; Escherichia coli Infections; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pseudomonas Infections; Sclera; Staphylococcal Infections; Visual Acuity; Young Adult	2021
Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents, 2017, Volume: 50, Issue:2 Topics: Animals; Anti-Bacterial Agents; Cancellous Bone; Cortical Bone; Debridement; Disease Models, Animal; Fluoroquinolones; Histocytochemistry; Humans; Injections, Intramuscular; Male; Methicillin-Resistant Staphylococcus aureus; Moxifloxacin; Osteomyelitis; Rabbits; Staphylococcal Infections; Treatment Outcome	2017
Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus. International journal of antimicrobial agents, 2018, Volume: 51, Issue:1 Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2018
Surface modification of an intraocular lens material by plasma-assisted grafting with 2-hydroxyethyl methacrylate (HEMA), for controlled release of moxifloxacin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 120 Topics: Animals; Anti-Bacterial Agents; Cornea; Delayed-Action Preparations; Endophthalmitis; Endothelial Cells; Fluoroquinolones; Lab-On-A-Chip Devices; Lenses, Intraocular; Methacrylates; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis	2017
Burn aggravated infected wart in a patient with type 2 diabetes: a medical challenge. BMJ case reports, 2018, Mar-28, Volume: 2018 Topics: Aged; Anti-Bacterial Agents; Burns; Cefepime; Cephalosporins; Diabetes Mellitus, Type 2; Fluoroquinolones; Foot; Foot Diseases; Humans; Male; Moxifloxacin; Pakistan; Saudi Arabia; Staphylococcal Infections; Staphylococcus aureus; Warts	2018
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis. Eye & contact lens, 2018, Volume: 44 Suppl 2 Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Intravitreal Injections; Male; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone	2018
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cornea; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Mice; Mice, Inbred BALB C; Moxifloxacin; Ophthalmic Solutions; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Trimethoprim	2019
Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery. European journal of ophthalmology, 2020, Volume: 30, Issue:5 Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Combinations; Drug Implants; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin, Dexamethasone Drug Combination; Triamcinolone; Vancomycin; Vitrectomy	2020
Antibiotic susceptibility of staphylococci isolates from patients with chronic conjunctivitis: including associated factors and clinical evaluation. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:9 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Conjunctivitis, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Treatment Outcome; Vancomycin	2013
Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus. Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Cinnamomum zeylanicum; Clindamycin; Curcuma; Fluoroquinolones; Garlic; Humans; Linezolid; Mentha; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Nigella sativa; Oxazolidinones; Pakistan; Plant Extracts; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Syzygium; Vancomycin Resistance; Wound Infection	2015
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anti-Bacterial Agents; Ceftazidime; Cells, Cultured; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Guanidines; Humans; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2015
Molecular Characterization of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates in Southern Taiwan. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Moxifloxacin; Staphylococcal Infections; Taiwan	2015
Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis. Ocular immunology and inflammation, 2017, Volume: 25, Issue:4 Topics: Animals; Anti-Bacterial Agents; Corneal Ulcer; Drug Delivery Systems; Emulsions; Escherichia coli; Eye Infections, Bacterial; Fluoroquinolones; Hexoses; Microscopy, Electron, Transmission; Moxifloxacin; Myristates; Oils; Particle Size; Phase Transition; Polysorbates; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Water	2017
Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years. Ocular immunology and inflammation, 2017, Volume: 25, Issue:6 Topics: Anti-Bacterial Agents; Conjunctiva; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus	2017
Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents, 2016, Volume: 48, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Fluoroquinolones; Gemifloxacin; Keratitis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Naphthyridines; Rabbits; Staphylococcal Infections; Treatment Outcome	2016
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Interactions; Fluoroquinolones; Humans; Kinetics; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tetrazoles; Trimethoprim, Sulfamethoxazole Drug Combination	2017
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Synergism; Fluoroquinolones; Gentamicins; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polysorbates; Quinolines; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surface-Active Agents; Vancomycin Resistance	2008
[Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci]. Biomedica : revista del Instituto Nacional de Salud, 2008, Volume: 28, Issue:2 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colombia; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterococcus; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae	2008
Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Aza Compounds; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin	2009
Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population. The International journal of artificial organs, 2008, Volume: 31, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Naphthyridines; Prosthesis-Related Infections; Quinolines; Quinolones; Staphylococcal Infections; Staphylococcus epidermidis	2008
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin. International journal of antimicrobial agents, 2009, Volume: 33, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bone and Bones; Calcium Sulfate; Colony Count, Microbial; Delayed-Action Preparations; Fluoroquinolones; Male; Methicillin-Resistant Staphylococcus aureus; Moxifloxacin; Osteomyelitis; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome	2009
High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy. The Journal of infection, 2009, Volume: 58, Issue:3 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Foreign Bodies; Levofloxacin; Male; Microbial Sensitivity Tests; Microbial Viability; Models, Animal; Moxifloxacin; Ofloxacin; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Time Factors	2009
Late-onset laser in situ keratomileusis-related corneal ulcer--a case series. Cornea, 2009, Volume: 28, Issue:5 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections; Surgical Flaps; Time Factors	2009
Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea, 2009, Volume: 28, Issue:9 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome	2009
Besifloxacin ophthalmic suspension 0.6%. Drugs, 2010, Volume: 70, Issue:1 Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Azepines; Colony Count, Microbial; Conjunctivitis, Bacterial; DNA Gyrase; DNA Topoisomerase IV; Double-Blind Method; Drug Administration Schedule; Eye; Fluoroquinolones; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suspensions	2010
Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:2 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Treatment Outcome	2010
Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2010, Volume: 28, Issue:10 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Disease Models, Animal; Fluoroquinolones; Injections, Intraperitoneal; Male; Moxifloxacin; Osteomyelitis; Prosthesis-Related Infections; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome	2010
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Prosthesis-Related Infections; Quinolines; Staphylococcal Infections	2010
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5 Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections	2010
Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:12 Topics: Animals; Anti-Infective Agents; Aqueous Humor; Aza Compounds; Azepines; Biological Availability; Colony-Forming Units Assay; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome	2010
Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Animals; Anti-Infective Agents; Aza Compounds; Cell Line; Culture Media; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Macrophages; Mice; Microbial Sensitivity Tests; Models, Biological; Monocytes; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus	2011
Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. Investigative ophthalmology & visual science, 2011, Mar-25, Volume: 52, Issue:3 Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intravenous; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin	2011
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Cell Line; Clindamycin; Community-Acquired Infections; Fluoroquinolones; Humans; Linezolid; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Oxazolidinones; Phagocytosis; Quinolines; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination	2011
Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2011, Volume: 69, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chromatography, High Pressure Liquid; Fluoroquinolones; Male; Moxifloxacin; Organotechnetium Compounds; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus	2011
Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:4 Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Risk Factors; Staphylococcal Infections; Staphylococcus aureus	2011
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:3 Topics: Anti-Bacterial Agents; Aza Compounds; Daptomycin; Endocarditis, Bacterial; Fibrinogen; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocytopenia; Vancomycin	2011
Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery. International ophthalmology, 2012, Volume: 32, Issue:1 Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Follow-Up Studies; Humans; Hyperopia; Keratitis; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Netilmicin; Ophthalmic Solutions; Photorefractive Keratectomy; Quinolines; Staphylococcal Infections; Visual Acuity	2012
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. The Journal of antibiotics, 2012, Volume: 65, Issue:5 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Fluoroquinolones; Intracellular Space; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Peritonitis; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Time Factors	2012
Corneal ulcer with Scopulariopsis brevicaulis and Staphylococcus aureus--a rare case report. Journal of the Indian Medical Association, 2012, Volume: 110, Issue:4 Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections; Fluoroquinolones; Humans; Male; Moxifloxacin; Natamycin; Quinolines; Scopulariopsis; Staphylococcal Infections; Staphylococcus aureus	2012
Bilateral corneal ulceration in keratoconus. Ophthalmology, 2012, Volume: 119, Issue:10 Topics: Aza Compounds; Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Doxycycline; Drug Therapy, Combination; Electrocoagulation; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconus; Male; Middle Aged; Moxifloxacin; Photosensitizing Agents; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin	2012
Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model. Current eye research, 2013, Volume: 38, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Endophthalmitis; Epithelium, Corneal; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intraocular; Microscopy, Electron, Transmission; Moxifloxacin; Phacoemulsification; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections; Vitreous Body	2013
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin	2002
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Endophthalmitis; Exotoxins; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors	2003
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Lymphoma, Large B-Cell, Diffuse; Macrophages; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Tumor Cells, Cultured	2003
Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Catheterization; Device Removal; Drug Interactions; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Glycopeptides; Humans; Italy; Male; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Risk Assessment; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Failure; Vancomycin; Vancomycin Resistance	2003
Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections. JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:1 Topics: Aza Compounds; Cross Infection; Fluoroquinolones; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus	2004
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6 Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cornea; Drug Resistance, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Staphylococcal Infections	2004
Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. American journal of ophthalmology, 2004, Volume: 138, Issue:1 Topics: Administration, Topical; Animals; Anterior Chamber; Aza Compounds; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus	2004
Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. The Tohoku journal of experimental medicine, 2005, Volume: 205, Issue:3 Topics: Adrenal Cortex Hormones; Animals; Anti-Infective Agents; Aza Compounds; Dexamethasone; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Inflammation; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Time Factors; Vitreous Body	2005
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Cornea, 2005, Volume: 24, Issue:2 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Methicillin Resistance; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2005
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology, 2005, Volume: 140, Issue:3 Topics: Animals; Anterior Chamber; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Ophthalmic Solutions; Quinolines; Rabbits; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body	2005
Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Cephalosporins; Fluoroquinolones; Genetic Variation; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Phenotype; Quinolines; Staphylococcal Infections; Staphylococcus	2005
Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology, 2006, Volume: 141, Issue:4 Topics: Animals; Anterior Chamber; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Quinolines; Rabbits; Staphylococcal Infections	2006
Treatment of implant-associated infections with moxifloxacin: an animal study. International journal of antimicrobial agents, 2006, Volume: 27, Issue:5 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Implants, Experimental; Male; Moxifloxacin; Osteomyelitis; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Vancomycin	2006
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:3 Topics: Adult; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Lasers, Excimer; Microbial Sensitivity Tests; Moxifloxacin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Pseudomonas Infections; Quinolines; Staphylococcal Infections	2006
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye (London, England), 2007, Volume: 21, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body	2007
Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats. Acta orthopaedica, 2006, Volume: 77, Issue:2 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Femur; Fluoroquinolones; Male; Moxifloxacin; Osteomyelitis; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2006
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Horses; Humans; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae	2006
Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Cell Line; Extracellular Space; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Levofloxacin; Lysosomes; Monocytes; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus	2007
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology, 2007, Volume: 114, Issue:5 Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin	2007
Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Current eye research, 2007, Volume: 32, Issue:4 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Aza Compounds; Colony Count, Microbial; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edema; Endophthalmitis; Fluoroquinolones; Hyperemia; Injections; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body	2007
Fourth-generation fluoroquinolone-resistant bacterial keratitis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:8 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin	2007
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus. Cornea, 2007, Volume: 26, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Keratoconus; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin	2007
Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis. Ophthalmic research, 2008, Volume: 40, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Aza Compounds; Cells, Cultured; Conjunctivitis; Endotoxins; Fluoroquinolones; Gatifloxacin; Immunologic Factors; Keratitis; Levofloxacin; Lipopolysaccharides; Macrophages, Peritoneal; Male; Methicillin Resistance; Mice; Mice, Inbred C3H; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tumor Necrosis Factor-alpha	2008
Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:2 Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratomileusis, Laser In Situ; Methicillin Resistance; Moxifloxacin; Postoperative Complications; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps	2008
Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea. Optometry (St. Louis, Mo.), 2008, Volume: 79, Issue:3 Topics: Administration, Oral; Administration, Topical; Adult; Aza Compounds; Blepharitis; Cyclosporine; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconjunctivitis; Male; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Rosacea; Staphylococcal Infections	2008
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus. Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 4 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Community-Acquired Infections; Cross Infection; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Virulence; Virulence Factors	2008
Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Topics: Administration, Topical; Animals; Anti-Infective Agents; Aza Compounds; Conjunctivitis; Endophthalmitis; Fluoroquinolones; Injections; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body	2008
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Reserpine; Staphylococcal Infections; Staphylococcus aureus	1998
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Virginiamycin	1999
Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Blotting, Northern; Blotting, Western; Coloring Agents; Congo Red; Cystic Fibrosis; Fluoroquinolones; Gentamicins; Granuloma; Hemolysis; HLA Antigens; Humans; Leukocyte Elastase; Male; Moxifloxacin; Penicillins; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus	2001
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:12 Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration	2000
Bactericidal activity of moxifloxacin against Staphylococcus aureus. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Endocarditis, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus	2001
Treatment of Staphylococcus aureus endocarditis using moxifloxacin. International journal of medical microbiology : IJMM, 2001, Volume: 291, Issue:3 Topics: Adult; Anti-Infective Agents; Aza Compounds; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus	2001
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rats; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2001